PubMed HealthSearch

PubMed · 6670435

Computerized data processing in the clinical laboratory.

Abstract

In order to satisfy the increasing demand for clinical chemical investigations, automatization is necessary. Computerized data processing facilitates administrative work. There are well-known fully automatized computerized systems, but they are too expensive. This paper presents our experiences with a 'hybrid' system, in which manual laboratory work is combined with computerized production of the daily list of laboratory work. The manpower needed had been decreased to one quarter, the work time from 126 minutes to 97 minutes, and the occurrence of errors from 0.72% to 0.21%. The system can be developed to produce laboratory reports, and for the continuous monitoring of data. In the case of pathological values the reports can be supplied with a warning signal and the system is suitable for the registration of laboratory statistics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Tanos. 1983. Computerized data processing in the clinical laboratory.. https://pubmed.ncbi.nlm.nih.gov/6670435/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Multivariate discriminant analysis of biochemical parameters for the differentiation of clinically confounding liver diseases.

We describe a series of studies on the contribution of laboratory medicine to the differential diagnosis of clinically confounding diseases in the field of chronic hepatobiliary diseases. Ascitic cholesterol and lactate dehydrogenase (LD), selected by multivariate discriminant analysis (MDA) from a multitude of serum and ascitic analytes, correctly classified 100% of patients with malignant ascites or non-malignant ascites. In addition, ascitic pseudouridine differentiated hepatocarcinoma (HC) from cirrhotic ascites with a diagnostic effectiveness (overall discrimination power) of 90%. A panel of analytes constituted by serum gamma-glutamyltransferase (GGT), the GGT isoenzyme complexed with low- and very low-density lipoprotein, aspartate aminotransferase, copper, hepatic alkaline phosphatase (AP), the LD-5 isoenzyme and alpha-fetoprotein (AFP), selected by the MDA, correctly classified 93% of about 200 cases of cirrhosis or HC. Finally, MDA also identified an equation, based on serum values of the LD-4/LD-5 and carcinoembryonic antigen/AFP ratios, AP and iron that correctly classified 96% of HC or secondary liver neoplasia cases in 100 patients. This approach based on panels of analytes selected by a sophisticated statistical analysis is a rapid and non-invasive contribution to the differential diagnosis of chronic liver disease including neoplasia.

Chemistry, Clinical